Reversing Radiation-Induced Immunosuppression Using a New Therapeutic Modality

Courtney, C. M.; Sharma, S.; Fallgren, C.; Weil, M.; Chatterjee, A.; Nagpal, P.

doi:10.1101/2022.05.03.490472

Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.05.03.490472

Reversing Radiation-Induced Immunosuppression Using a New Therapeutic Modality

Courtney, C. M.·Sharma, S.·Fallgren, C.·Weil, M.·Chatterjee, A.·Nagpal, P.

View original source ↗Export metadata ↓

Abstract

Radiation-induced immune suppression poses significant health challenges for millions of patients undergoing cancer chemotherapy and radiotherapy treatment, and astronauts and space tourists travelling to outer space. While a limited number of recombinant protein therapies, such a Sargramostim, are approved for accelerating hematologic recovery, the pronounced role of granulocyte-macrophage colony-stimulating factor (GM-CSF or CSF2) as a proinflammatory cytokine poses additional challenges in creating immune dysfunction towards pathogenic autoimmune diseases. Here we present an approach to high-throughput drug-discovery, target validation, and lead molecule identification using nucleic acid-based molecules. These Nanoligomer molecules are rationally designed using a bioinformatics and an artificial intelligence (AI)-based ranking method and synthesized as a single-modality combining 6-different design elements to up- or downregulate gene expression of target gene, resulting in elevated or diminished protein expression of intended target. This method additionally alters related gene network targets ultimately resulting in pathway modulation. This approach was used to perturb and identify the most effective upstream regulators and canonical pathways for therapeutic intervention to reverse radiation-induced immunosuppression. The lead Nanoligomer identified in a screen of human donor derived peripheral blood mononuclear cells (PBMCs) upregulated Erythropoietin (EPO) and showed the greatest reversal of radiation induced cytokine changes. It was further tested in vivo in a mouse radiation-model with low-dose (3 mg/kg) intraperitoneal administration and was shown to regulate gene expression of epo in lung tissue as well as counter immune suppression. These results point to the broader applicability of our approach towards drug-discovery, and potential for further investigation of lead molecule as reversible gene therapy to treat adverse health outcomes induced by radiation exposure.

Source connections

Published article ↗

Explore related subjects

genomics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Courtney, C. M., Sharma, S., Fallgren, C., Weil, M., Chatterjee, A., Nagpal, P.. 2022-05-04. Reversing Radiation-Induced Immunosuppression Using a New Therapeutic Modality. https://doi.org/10.1101/2022.05.03.490472

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

MicroDUET: a dual-headed genomic foundation model for pathogen surveillance

Pathogen genomic surveillance works from raw reads, assembled genomes and alignments, representations that are slow and costly to compare at scale. Compact embeddings from genomic language models offer an alternative, but surveillance requires resolving both evolutionary ancestry (phylogeny) and phenotypic capability (function) - which need not co-vary. Here we present MicroDUET, which adapts a 26.6-million-parameter ProkBERT backbone with two 3.5-million-parameter adapter heads: a phylogeny head trained contrastively on genome windows from the same microbes, and a function head trained to identify genes across taxa. On held-out retrieval benchmarks, the phylogeny head returned the correct species for 80.3% and 66.6% of cellular and viral queries, and the function head the correct gene family for 97.3% and 97.2%, reaching 74.4% accuracy on an independent antimicrobial resistance-class benchmark. Across all three benchmarks MicroDUET outranked 17 other genomic encoders. Without training on lineage, clade or drug-susceptibility tasks, MicroDUET identified Mycobacterium tuberculosis and mpox virus lineages and clades (0.965, 0.975 accuracy), discriminated rifampicin resistance without lineage adjustment (AUROC 0.985), and retrospectively identified an emerging mpox lineage as anomalous (AUROC 0.974). MicroDUET operates 10^3 - 10^4 times faster than single-threaded sequence-based alignments. MicroDUET therefore provides a compact, reusable representation for scalable pathogen surveillance and sequence triage.

genomics↗

bioRxiv2026

A chromosome-level genome assembly of northern dragonhead, Dracocephalum ruyschiana L., 1753

We present a chromosome-level genome assembly for the vascular plant northern dragonhead, Dracocephalum ruyschiana. The assembly comprises two pseudo-haplotypes, hap1 and hap2, of 661 Mb and 681 Mb, with 93.6% and 92.5%, respectively, scaffolded into seven chromosomes each - in line with the known karyotype. Assembly quality was high, with conserved single-copy ortholog completeness scores of 97.9% and 97.8%, combined k-mer completeness of 98.1%, and 38,141 and 38,617 annotated protein-coding genes for hap1 and hap2, respectively. This assembly provides a high-quality genomic resource for future research and conservation of northern dragonhead, as well as the endangered northern dragonhead sap beetle, which depends on the plant for reproduction and whose genome assembly is described in a complementary genome note.

genomics↗

bioRxiv2026

Elucidating Bat SuperImmunity: Insights from the Bent-Wing Bat Genome Assembly and Multi-Omics Analysis

Bats have evolved a range of unique adaptations, including powered flight, echolocation, and exceptional longevity. They have also attracted considerable scientific attention, particularly since the COVID-19 pandemic, due to their association with a broad diversity of viruses and their potential role in zoonotic transmission and emerging infectious diseases. Despite hosting numerous viruses, bats often exhibit limited clinical manifestations of infection, suggesting the evolution of distinctive mechanisms of immune regulation and tolerance. Understanding the molecular basis of these mechanisms has become a major focus of current research, with genome-wide analyses providing important insights into the genetic adaptations underlying bat immunity. Nevertheless, the regulatory complexity of bat genomes, particularly the contribution of non-coding RNAs and post-transcriptional RNA editing, remains comparatively underexplored. Here, we present an integrated multi-omic framework for the common bent-wing bat (Miniopterus schreibersii), combining a contiguous chromosome-scale genome assembly with multi-tissue transcriptomic profiling, long non-coding RNA (lncRNA) identification and synteny analysis, endogenous viral elements (EVE) mapping, and same-individual RNA editomic analyses. This study provides a comprehensive resource for investigating genome organization, transcriptional regulation, evolutionary relationships, and post-transcriptional modifications in this species. In particular, it offers an opportunity to explore the potential contribution of non-coding regulatory elements and RNA editing to the molecular mechanisms underlying viral interactions and immune regulation in bats. Collectively, these resources provide a valuable foundation for advancing our understanding of bat genome evolution and the regulatory mechanisms potentially associated with their distinctive responses to viral infections.

genomics↗